SK14552001A3 - Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady - Google Patents

Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady Download PDF

Info

Publication number
SK14552001A3
SK14552001A3 SK1455-2001A SK14552001A SK14552001A3 SK 14552001 A3 SK14552001 A3 SK 14552001A3 SK 14552001 A SK14552001 A SK 14552001A SK 14552001 A3 SK14552001 A3 SK 14552001A3
Authority
SK
Slovakia
Prior art keywords
treatment
osanetant
mood disorders
use according
disorders
Prior art date
Application number
SK1455-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Xavier Emonds-Alt
Philippe Soubrie
Regis Steinberg
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK14552001A3 publication Critical patent/SK14552001A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
SK1455-2001A 1999-04-13 2000-04-11 Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady SK14552001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
PCT/FR2000/000924 WO2000061125A2 (fr) 1999-04-13 2000-04-11 L'osanetant dans le traitement des troubles de l'humeur

Publications (1)

Publication Number Publication Date
SK14552001A3 true SK14552001A3 (sk) 2002-02-05

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1455-2001A SK14552001A3 (sk) 1999-04-13 2000-04-11 Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady

Country Status (24)

Country Link
US (1) US6420388B1 (fr)
EP (1) EP1175215A2 (fr)
JP (1) JP2002541190A (fr)
KR (1) KR20010105418A (fr)
CN (1) CN1354662A (fr)
AR (1) AR023452A1 (fr)
AU (1) AU3971600A (fr)
BR (1) BR0009704A (fr)
CA (1) CA2369638A1 (fr)
CZ (1) CZ20013645A3 (fr)
EE (1) EE200100527A (fr)
FR (1) FR2792199B3 (fr)
HR (1) HRP20010741A2 (fr)
HU (1) HUP0200655A3 (fr)
ID (1) ID30458A (fr)
IS (1) IS6098A (fr)
MX (1) MXPA01010340A (fr)
NO (1) NO20014953L (fr)
PE (1) PE20010032A1 (fr)
PL (1) PL351554A1 (fr)
SK (1) SK14552001A3 (fr)
TR (1) TR200102930T2 (fr)
WO (1) WO2000061125A2 (fr)
ZA (1) ZA200108289B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095904A1 (fr) * 2000-06-12 2001-12-20 University Of Rochester Methode de traitement de symptomes de la variation hormonale, tels que les bouffees de chaleur, au moyen d'un antagoniste du recepteur de la tachykinine
WO2005061544A2 (fr) * 2003-12-22 2005-07-07 Glaxo Group Limited Immunoglobulines
JP2007530591A (ja) * 2004-03-25 2007-11-01 スミスクライン・ビーチャム・コーポレイション 双極性障害を治療するための、ｎｋ３アンタゴニストの使用
EP1867717A4 (fr) * 2005-03-15 2008-08-20 Sumitomo Chemical Co Procédé destiné à améliorer les symptômes provenant de troubles de l'humeur
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP3915560A1 (fr) 2014-06-25 2021-12-01 Emory University Procédés de gestion d'une peur conditionnée à l'aide d'antagonistes du récepteur de la neurokinine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) * 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
EP1175215A2 (fr) 2002-01-30
PL351554A1 (en) 2003-05-05
TR200102930T2 (tr) 2002-04-22
CZ20013645A3 (cs) 2002-01-16
NO20014953L (no) 2001-12-11
NO20014953D0 (no) 2001-10-11
US6420388B1 (en) 2002-07-16
AU3971600A (en) 2000-11-14
FR2792199A1 (fr) 2000-10-20
EE200100527A (et) 2002-12-16
IS6098A (is) 2001-09-28
ZA200108289B (en) 2002-12-24
AR023452A1 (es) 2002-09-04
CA2369638A1 (fr) 2000-10-19
PE20010032A1 (es) 2001-04-11
HUP0200655A2 (hu) 2002-07-29
JP2002541190A (ja) 2002-12-03
KR20010105418A (ko) 2001-11-28
FR2792199B3 (fr) 2001-05-18
BR0009704A (pt) 2002-01-08
CN1354662A (zh) 2002-06-19
HUP0200655A3 (en) 2002-11-28
MXPA01010340A (es) 2002-05-06
ID30458A (id) 2001-12-06
WO2000061125A3 (fr) 2001-04-19
WO2000061125A2 (fr) 2000-10-19
HRP20010741A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
RU2384333C2 (ru) Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин
JP4925074B2 (ja) ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
EA007274B1 (ru) Применение флибансерина для лечения половых расстройств
CZ294087B6 (cs) Farmaceutický prostředek
AU737590B2 (en) Use of mirtazapine for treating sleep apneas
SK286075B6 (sk) Použitie bradykardických látok a voliteľne jednejďalšej zlúčeniny pôsobiacej na srdce
ZA200508068B (en) Combination of paroxetine and 4- (s) -4-acetyl-piperazin-1-yl)-2-(R)-(4-fluoro-2-methyl-phenyl-piperidine-1-carboxylic acid acid [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]methylamide for treatment of depression and/or anxiety
SK14552001A3 (sk) Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady
PL196479B1 (pl) Zastosowanie saredutantu i jego farmaceutycznie dopuszczalnych soli do wytwarzania leków
RU2261098C2 (ru) Перорально распадающаяся композиция, содержащая миртазапин
WO1998024411A2 (fr) Procede d'administration par voie orale de buspirone
EP1420782B1 (fr) Utilisation de la nefiracetame dans le traitement des affections neurodegeneratives post-ischemiques
US3497596A (en) Method of treating parkinsonism with morphanthridine derivatives
KR20010110798A (ko) 신경퇴화의 치료방법
JP2005526713A (ja) 慢性的疼痛、興奮毒性に関連した脳障害及び心臓不整脈の治療へのアンブロキソールの使用
EP1345599A1 (fr) Traitement d'un trouble obsessionnel-compulsif
JP2610735B2 (ja) 抗鬱剤および抗ストレス剤組成物
JP3935539B2 (ja) フマル酸ケトチフェン含有医薬組成物
SK19192000A3 (sk) Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
CN115813932A (zh) 一种用于重度抑郁症治疗的新的药物组合
WO2002043727A1 (fr) Traitement de troubles psychiques accompagnes d'un comportement social inadapte au moyen de dérivés de triméthylbicyclo[2.2.1]heptane